Jasper Ridge Partners’s Gilead Sciences GILD Stock Holding History

Jasper Ridge Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,000	Closed	-$1.24M	–	145
2023 Q1	$1.24M	Hold	15,000	–	–	0.06%	73
2022 Q4	$1.29M	Hold	15,000	–	–	0.08%	69
2022 Q3	$925K	Sell	15,000 -294	-2%	-$18.5K	0.06%	83
2022 Q2	$945K	Hold	15,294	–	–	0.06%	84
2022 Q1	$909K	Hold	15,294	–	–	0.04%	91
2021 Q4	$1.11M	Hold	15,294	–	–	0.04%	95
2021 Q3	$1.07M	Hold	15,294	–	–	0.05%	98
2021 Q2	$1.05M	Buy	15,294 +294	+2%	+$19.6K	0.05%	93
2021 Q1	$969K	Hold	15,000	–	–	0.04%	87
2020 Q4	$874K	Hold	15,000	–	–	0.04%	85
2020 Q3	$948K	Hold	15,000	–	–	0.05%	77
2020 Q2	$1.15M	Hold	15,000	–	–	0.08%	65
2020 Q1	$1.12M	Hold	15,000	–	–	0.09%	57
2019 Q4	$975K	Buy	+15,000	New	+$977K	0.06%	59

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jasper Ridge Partners's GILD Position: Q2 2023 in Review

Jasper Ridge Partners sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 15,000 shares — an estimated $1.24M sold.

Jasper Ridge Partners first reported a position in GILD in Q4 2019 and held it in 14 quarters. The position peaked at $1.29M in Q4 2022. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

Jasper Ridge Partners reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
Jasper Ridge Partners sold 15,000 Gilead Sciences shares in Q2 2023, an estimated $1.24M.
Jasper Ridge Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 14 quarters.
Jasper Ridge Partners's Gilead Sciences position peaked at $1.29M in Q4 2022.
1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Jasper Ridge Partners's 13F filing for Q2 2023, filed 14 Aug 2023.